|
Market Cap | 10.56B | EPS (ttm) | 0.20 |
P/E | 168.00 | EPS this Y | -0.17% |
Forward P/E | 11.99 | EPS next Y | 427.43% |
PEG | - | EPS past 5Y | - |
P/S | 2.43 | EPS next 5Y | - |
P/B | 1.49 | EPS Q/Q | -82.96% |
Dividend | - | Sales Q/Q | -13.21% |
Insider Own | 8.15% | Inst Own | 81.42% |
Insider Trans | -8.27% | Inst Trans | -3.32% |
Short Float | 4.18% | Earnings | Apr 24/a |
Analyst Recom | 2.13 | Target Price | 34.44 |
Avg Volume | 4.91M | 52W Range | 19.91 - 34.99 |
|
|
|
Antero Resources Corp. engages in the development, production, exploration, and acquisition of natural gas. It operates through the following segments: Exploration and Production, Marketing, and Equity Method Investment in Antero Midstream. The Exploration and Production segment deals with the development and production of natural gas, NGLs, and oil. The Marketing segment refers to marketing and utilization of excess firm transportation capacity. The Equity Method Investment in Antero Midstream segment represents midstream services. The company was founded by Paul M. Rady and Glen C. Warren, Jr. in June 2002 and is headquartered in Denver, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Kennedy Michael N. | See Remarks | May 14 '24 | Sale | 33.72 | 50,000 | 1,686,000 | 1,032,251 | May 14 06:35 PM | Keenan W Howard JR | Director | May 10 '24 | Sale | 33.30 | 162,993 | 5,427,667 | 2,000,000 | May 10 09:32 PM | Keenan W Howard JR | Director | May 09 '24 | Sale | 34.23 | 300,000 | 10,269,000 | 2,162,993 | May 09 06:44 PM | Keenan W Howard JR | Director | May 08 '24 | Sale | 34.35 | 437,007 | 15,011,190 | 2,462,993 | May 09 06:44 PM | Keenan W Howard JR | Director | May 07 '24 | Sale | 34.53 | 100,000 | 3,453,000 | 2,900,000 | May 09 06:44 PM |
|
|
|
|
Market Cap | 510.19M | EPS (ttm) | 0.72 |
P/E | 23.25 | EPS this Y | 17.82% |
Forward P/E | 13.03 | EPS next Y | 23.64% |
PEG | - | EPS past 5Y | -2.11% |
P/S | 1.26 | EPS next 5Y | - |
P/B | 1.54 | EPS Q/Q | 121.25% |
Dividend | 2.51% | Sales Q/Q | 12.92% |
Insider Own | 16.64% | Inst Own | 83.40% |
Insider Trans | -3.74% | Inst Trans | -3.09% |
Short Float | 3.59% | Earnings | May 07/a |
Analyst Recom | 1.64 | Target Price | 18.14 |
Avg Volume | 377.71K | 52W Range | 7.22 - 17.27 |
|
|
|
Aris Water Solutions, Inc. engages in full-cycle water handling and recycling solutions. It gathers, transports, and, unless recycled, handles produced water generated from oil and natural gas production. It also develops and operates recycling facilities to treat, store, and recycle produced water. The company was founded by William A. Zartler in November 2015 and is headquartered in Houston, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Brock Amanda M | President and CEO | May 14 '24 | Sale | 16.64 | 30,000 | 499,200 | 457,909 | May 14 06:35 PM | Brock Amanda M | President and CEO | May 13 '24 | Sale | 16.43 | 62,054 | 1,019,547 | 487,909 | May 14 06:35 PM | Brock Amanda M | President and CEO | May 10 '24 | Sale | 16.65 | 107,946 | 1,797,301 | 549,963 | May 14 06:35 PM | Hernandez Jacinto J | Director | Dec 13 '23 | Buy | 7.42 | 2,756 | 20,450 | 21,072 | Dec 13 05:28 PM |
|
|
|
|
Market Cap | 71.70B | EPS (ttm) | 22.37 |
P/E | 24.66 | EPS this Y | 15.11% |
Forward P/E | 15.45 | EPS next Y | 13.01% |
PEG | 2.11 | EPS past 5Y | 164.60% |
P/S | 0.23 | EPS next 5Y | 11.66% |
P/B | - | EPS Q/Q | 5.40% |
Dividend | 0.46% | Sales Q/Q | 10.80% |
Insider Own | 0.06% | Inst Own | 88.56% |
Insider Trans | -19.16% | Inst Trans | -1.31% |
Short Float | 1.58% | Earnings | May 07/a |
Analyst Recom | 1.63 | Target Price | 596.35 |
Avg Volume | 675.61K | 52W Range | 373.28 - 566.01 |
|
|
|
McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SALKA SUSAN R | Director | May 13 '24 | Sale | 554.61 | 1 | 541 | 0 | May 14 06:31 PM | SALKA SUSAN R | Director | May 10 '24 | Sale | 558.04 | 606 | 338,171 | 0 | May 14 06:31 PM | SALKA SUSAN R | Director | May 10 '24 | Sale | 558.04 | 4 | 2,232 | 1 | May 14 06:31 PM | TYLER BRIAN S. | Chief Executive Officer | Mar 15 '24 | Option Exercise | 159.00 | 3,473 | 552,207 | 46,918 | Mar 18 06:35 PM | TYLER BRIAN S. | Chief Executive Officer | Mar 15 '24 | Sale | 524.55 | 3,473 | 1,821,762 | 43,445 | Mar 18 06:35 PM |
|
|
| |
|
Market Cap | 3.89B | EPS (ttm) | -3.77 |
P/E | - | EPS this Y | 3.69% |
Forward P/E | - | EPS next Y | -6.57% |
PEG | - | EPS past 5Y | -10.59% |
P/S | - | EPS next 5Y | - |
P/B | 4.43 | EPS Q/Q | -8.52% |
Dividend | - | Sales Q/Q | - |
Insider Own | 7.45% | Inst Own | 89.76% |
Insider Trans | -5.57% | Inst Trans | 1.40% |
Short Float | 6.72% | Earnings | May 09/a |
Analyst Recom | 1.21 | Target Price | 61.64 |
Avg Volume | 840.26K | 52W Range | 15.76 - 51.29 |
|
|
|
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Betz Stephen F. | Chief Scientific Officer | May 10 '24 | Sale | 49.43 | 3,000 | 148,290 | 89,643 | May 14 06:29 PM | Struthers Richard Scott | President & CEO | May 08 '24 | Option Exercise | 9.28 | 107,448 | 997,117 | 364,933 | May 10 04:57 PM | Struthers Richard Scott | President & CEO | May 08 '24 | Sale | 49.40 | 107,448 | 5,307,931 | 257,485 | May 10 04:57 PM | Pizzuti Dana | Chief Med and Dev Officer | Apr 15 '24 | Option Exercise | 16.89 | 14,375 | 242,794 | 42,161 | Apr 17 04:36 PM | Struthers Richard Scott | President & CEO | Apr 15 '24 | Option Exercise | 1.91 | 20,000 | 38,200 | 257,835 | Apr 17 04:30 PM |
|
|
|
|
Market Cap | 216.57M | EPS (ttm) | -0.64 |
P/E | - | EPS this Y | 39.34% |
Forward P/E | - | EPS next Y | 21.82% |
PEG | - | EPS past 5Y | -13.35% |
P/S | 0.66 | EPS next 5Y | - |
P/B | 2.35 | EPS Q/Q | 21.95% |
Dividend | - | Sales Q/Q | 4.83% |
Insider Own | 31.11% | Inst Own | 60.27% |
Insider Trans | -2.96% | Inst Trans | -4.17% |
Short Float | 8.63% | Earnings | May 06/a |
Analyst Recom | 1.17 | Target Price | 4.00 |
Avg Volume | 617.16K | 52W Range | 1.51 - 4.39 |
|
|
|
thredUP, Inc. operates as an online clothing resale platform for apparel, shoes, and accessories. Its brands include J.Crew, Ann Taylor, Banana Republic, Lululemon Athletica, Talbots, and Madewell. It operates through the United States and Others geographical segments. The company was founded by James Reinhart, Chris Homer, and Oliver Lubin in January 2009 and is headquartered in Oakland, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Nakache Patricia | Director | May 14 '24 | Sale | 2.01 | 101,630 | 204,276 | 0 | May 14 06:29 PM | Nakache Patricia | Director | May 13 '24 | Sale | 2.06 | 75,217 | 154,947 | 0 | May 14 06:29 PM | Nakache Patricia | Director | May 10 '24 | Sale | 2.05 | 149,327 | 306,120 | 0 | May 14 06:29 PM | Rotem Alon | Chief Legal Officer | May 09 '24 | Sale | 2.00 | 10,000 | 20,000 | 210,771 | May 13 05:07 PM | Nakache Patricia | Director | May 07 '24 | Sale | 1.92 | 314,034 | 602,945 | 0 | May 07 06:01 PM |
|
|
| |
|
Market Cap | 226.93M | EPS (ttm) | -0.52 |
P/E | - | EPS this Y | 35.30% |
Forward P/E | - | EPS next Y | 25.62% |
PEG | - | EPS past 5Y | - |
P/S | 17.65 | EPS next 5Y | - |
P/B | 1.89 | EPS Q/Q | 26.92% |
Dividend | - | Sales Q/Q | 38.66% |
Insider Own | 30.31% | Inst Own | 18.18% |
Insider Trans | -0.45% | Inst Trans | -8.91% |
Short Float | 14.85% | Earnings | May 09/a |
Analyst Recom | 1.00 | Target Price | 3.17 |
Avg Volume | 7.05M | 52W Range | 0.46 - 3.43 |
|
|
|
Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rivas David | CHIEF TECHNOLOGY OFFICER | May 14 '24 | Sale | 1.34 | 4,433 | 5,940 | 1,376,007 | May 14 06:21 PM | Danis Richard | GENERAL COUNSEL & CORP. SEC. | May 14 '24 | Sale | 1.34 | 3,804 | 5,097 | 1,048,337 | May 14 06:20 PM | Danis Richard | GENERAL COUNSEL & CORP. SEC. | Mar 18 '24 | Sale | 1.97 | 46,326 | 91,262 | 1,052,141 | Mar 18 05:39 PM | Rivas David | CHIEF TECHNOLOGY OFFICER | Mar 18 '24 | Sale | 1.97 | 9,273 | 18,268 | 880,440 | Mar 18 05:41 PM | Fitzgerald Alissa | Director | Mar 01 '24 | Option Exercise | 0.27 | 34,747 | 9,451 | 175,557 | Mar 05 04:15 PM |
|
|
|
|
Market Cap | 1.60B | EPS (ttm) | 1.23 |
P/E | 86.60 | EPS this Y | 12.98% |
Forward P/E | 33.55 | EPS next Y | 9.66% |
PEG | 9.52 | EPS past 5Y | -0.50% |
P/S | 2.62 | EPS next 5Y | 9.10% |
P/B | 3.34 | EPS Q/Q | -19.32% |
Dividend | 1.65% | Sales Q/Q | 4.83% |
Insider Own | 1.66% | Inst Own | 104.35% |
Insider Trans | -6.79% | Inst Trans | -3.15% |
Short Float | 4.77% | Earnings | May 07/a |
Analyst Recom | 1.33 | Target Price | 120.50 |
Avg Volume | 73.12K | 52W Range | 78.08 - 124.11 |
|
|
|
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the Physical Therapy Operations and Industrial Injury Prevention Services segments. The Physical Therapy Operations segment consists of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The Industrial Injury Prevention Services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The company was founded in 1990 and is headquartered in Houston, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Williams Eric Joseph | Co-Chief Operations Officer | May 10 '24 | Sale | 104.22 | 2,500 | 260,550 | 16,814 | May 14 06:19 PM | REEVE GRAHAM D. | COO | May 10 '24 | Sale | 105.46 | 1,724 | 181,813 | 6,970 | May 14 06:15 PM | Binstein Richard | EVP Gen'l Counsel & Secretary | Mar 13 '24 | Sale | 106.55 | 2,000 | 213,100 | 15,006 | Mar 14 05:11 PM | HENDRICKSON CAREY P | Chief Financial Officer | Mar 13 '24 | Sale | 107.28 | 1,800 | 193,103 | 21,186 | Mar 14 05:23 PM | HAM NANCY | Director | Mar 13 '24 | Sale | 107.89 | 500 | 53,945 | 860 | Mar 14 04:21 PM |
|
|
| |
|
Market Cap | 1.45B | EPS (ttm) | -2.49 |
P/E | - | EPS this Y | -19.05% |
Forward P/E | - | EPS next Y | 24.21% |
PEG | - | EPS past 5Y | -84.59% |
P/S | - | EPS next 5Y | - |
P/B | 4.89 | EPS Q/Q | -22.24% |
Dividend | - | Sales Q/Q | - |
Insider Own | 30.65% | Inst Own | 75.70% |
Insider Trans | -0.91% | Inst Trans | 2.05% |
Short Float | 18.47% | Earnings | May 06/a |
Analyst Recom | 1.55 | Target Price | 35.78 |
Avg Volume | 1.09M | 52W Range | 9.67 - 18.07 |
|
|
|
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Blackman Samuel C. | HEAD OF R&D | May 10 '24 | Sale | 16.37 | 10,000 | 163,743 | 1,164,662 | May 14 06:13 PM | Bender Jeremy | CHIEF EXECUTIVE OFFICER | May 03 '24 | Sale | 17.85 | 9,154 | 163,417 | 642,602 | May 03 06:48 PM | York Charles N II | COO, CFO AND SECRETARY | May 03 '24 | Sale | 17.85 | 8,078 | 144,214 | 217,293 | May 03 06:44 PM | York Charles N II | COO, CFO AND SECRETARY | May 02 '24 | Sale | 17.90 | 200 | 3,579 | 225,371 | May 03 06:44 PM | Bender Jeremy | CHIEF EXECUTIVE OFFICER | May 02 '24 | Sale | 17.94 | 6 | 108 | 651,756 | May 03 06:48 PM |
|
|
|
|
Market Cap | 140.53B | EPS (ttm) | 2.55 |
P/E | 41.46 | EPS this Y | 6.68% |
Forward P/E | 17.25 | EPS next Y | 13.49% |
PEG | 3.62 | EPS past 5Y | -19.30% |
P/S | 1.98 | EPS next 5Y | 11.44% |
P/B | 2.32 | EPS Q/Q | 32.12% |
Dividend | 2.32% | Sales Q/Q | 12.15% |
Insider Own | 0.10% | Inst Own | 85.74% |
Insider Trans | -10.61% | Inst Trans | -1.09% |
Short Float | 2.55% | Earnings | Apr 23/b |
Analyst Recom | 2.52 | Target Price | 105.96 |
Avg Volume | 8.00M | 52W Range | 68.56 - 107.82 |
|
|
|
RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Timm Stephen J. | President, Collins Aerospace | May 10 '24 | Option Exercise | 87.13 | 112,992 | 9,844,780 | 168,930 | May 14 06:08 PM | Timm Stephen J. | President, Collins Aerospace | May 10 '24 | Sale | 105.72 | 19,880 | 2,101,624 | 149,050 | May 14 06:08 PM | Ortberg Robert Kelly | Director | Apr 30 '24 | Sale | 101.97 | 10,295 | 1,049,732 | 129,120 | May 02 05:03 PM | Mitchill Neil G. JR | EVP, Chief Financial Officer | Apr 26 '24 | Option Exercise | 0.00 | 3,986 | 0 | 68,770 | Apr 30 05:03 PM | HAYES GREGORY | Chairman and CEO | Apr 25 '24 | Option Exercise | 76.58 | 365,618 | 27,999,717 | 932,341 | Apr 29 05:06 PM |
|
|
|
|
Market Cap | 1.16B | EPS (ttm) | 6.11 |
P/E | 27.38 | EPS this Y | 11.17% |
Forward P/E | 24.96 | EPS next Y | 10.43% |
PEG | 2.74 | EPS past 5Y | 15.58% |
P/S | 1.80 | EPS next 5Y | 10.00% |
P/B | 5.44 | EPS Q/Q | 58.87% |
Dividend | 0.93% | Sales Q/Q | 12.39% |
Insider Own | 4.48% | Inst Own | 87.41% |
Insider Trans | -5.56% | Inst Trans | -0.13% |
Short Float | 1.03% | Earnings | May 02/b |
Analyst Recom | 2.00 | Target Price | 167.00 |
Avg Volume | 30.79K | 52W Range | 81.29 - 166.43 |
|
|
|
CRA International, Inc. is a consulting firm, which engages in provision of economic, financial and management consulting services. It offers consulting services through the litigation, regulatory, financial, and management consulting areas. The company was founded in 1965 and is headquartered in Boston, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Detrick Christine Rose | Director | May 10 '24 | Sale | 164.06 | 2,500 | 410,138 | 4,743 | May 14 06:07 PM | Maleh Paul A | PRESIDENT AND CEO | Mar 12 '24 | Sale | 138.66 | 7,500 | 1,039,916 | 170,280 | Mar 14 05:46 PM | Mahoney Daniel K. | EVP, CFO AND TREASURER | Mar 11 '24 | Sale | 138.31 | 1,000 | 138,309 | 10,496 | Mar 12 06:00 PM | Yellin Jonathan D | EVP AND GENERAL COUNSEL | Mar 07 '24 | Sale | 136.62 | 1,250 | 170,781 | 21,587 | Mar 11 05:26 PM | Avery Thomas Aiken | Director | Mar 04 '24 | Sale | 138.05 | 1,000 | 138,054 | 15,504 | Mar 06 07:19 PM |
|
|
|